$KDNY
Chinook Therapeutics Inc
PRICE
$25.1 -
Extented Hours
VOLUME
1,265,532
DAY RANGE
24.1968 - 25.92
52 WEEK
15.08 - 27.44
Key Metrics
Market Cap
1.69 B
Beta
0.99
Avg. Volume
819.31 K
Shares Outstanding
66.89 M
Yield
0%
Public Float
0
Next Earnings Date
2023-08-07
Next Dividend Date
Company Information
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater understanding of disease biology, utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.
CEO: Stephen Isaacs
Website: http://www.aduro.com/
HQ: 740 Heinz Ave Berkeley, 94710-2748 California
Related News